December 17, 2012
A Tennessee federal judge on Thursday barred portions of expert testimony in cases stemming from multidistrict litigation against Novartis Pharmaceuticals Corp. over jaw damage blamed on osteoporosis drugs Aredia and Zometa, calling the witness unqualified to speak about links between the medications and bone loss.